Select for export Psychedelic-Assisted Therapy for People with Eating Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01394-5 PubMed 36374357 Copy citation Copy BibTeX Current psychiatry reports 2022-11-30 Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS PubMed Published psilocybin Eating DisordersMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221125354 PubMed 36433778 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-25 Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-11-15 NWTraumatherapies ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionPTSDEnd-of-Life Distress Other More
Select for export Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.11.15.516655 Copy citation Copy BibTeX bioRxiv 2022-11-14 Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. bioRxiv PREPRINT (not peer reviewed) psilocin NeuroplasticityMechanism of ActionReceptor Pharmacology Animal Study More
Select for export 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.11.03.515044 Copy citation Copy BibTeX bioRxiv 2022-11-02 Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyNeuroplasticity Animal Study More
Select for export The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11064-022-03772-0 PubMed 36327017 Copy citation Copy BibTeX Unknown journal 2022-11-02 VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Review Article More
Select for export The psychedelic renaissance: can psilocybin possibly combat depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/gh9.0000000000000089 Copy citation Copy BibTeX International Journal of Surgery Global Health 2022-10-31 Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh OpenAlex Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1681/asn.20223311s1895a Copy citation Copy BibTeX Journal of the American Society of Nephrology 2022-10-31 Syed Rizwan A. Bokhari, Ahmad Makmom Abdullah, Zamir A. Zamir, Raquel M. Rosen OpenAlex Published psilocybin PharmacologyMechanism of ActionAdverse Events Other More
Select for export Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.10.31.22281688 Copy citation Copy BibTeX medRxiv 2022-10-31 Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J medRxiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionBiomarkers Other More
Select for export Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/adb.13229 PubMed 36301215 Copy citation Copy BibTeX Unknown journal 2022-10-31 Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Systematic Review More
Select for export Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/13634615221131465 PubMed 36263513 Copy citation Copy BibTeX Unknown journal 2022-10-18 Dupuis D, Veissière S. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2022-066019 PubMed 36241352 Copy citation Copy BibTeX BMJ Open 2022-10-13 Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM Europe PMC Published psilocybinpsilocin AddictionBrain ImagingMechanism of Action Randomized Controlled Trial More
Select for export Mescaline: The forgotten psychedelic. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109294 PubMed 36252614 Copy citation Copy BibTeX Unknown journal 2022-10-13 Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Review Article More
Select for export A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.991753 PubMed 36311515 Copy citation Copy BibTeX Unknown journal 2022-10-11 Sottile RJ, Vida T. Europe PMC Published psilocybin AnxietyPTSDMechanism of Action Other More
Select for export Potential Therapeutic Effects of Psilocybin: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.30214 PubMed 36381758 Copy citation Copy BibTeX Unknown journal 2022-10-11 Goel DB, Zilate S. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Predictors of Psychedelic Experience: A Thematic Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2129885 PubMed 36197103 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-10-04 McCartney AM, McGovern HT, De Foe A. Europe PMC Published psilocybin Mechanism of Action Other More
Select for export Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules27196576 PubMed 36235111 Copy citation Copy BibTeX Molecules (Basel, Switzerland) 2022-10-03 Liu Y, Guo ZJ, Zhou XW PubMed Published psilocybin Mechanism of ActionReview ArticleImmune Function Review Article More
Select for export 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.990405 PubMed 36262632 Copy citation Copy BibTeX Unknown journal 2022-10-02 López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M Europe PMC Published psilocybin DepressionPTSDMechanism of Action Review Article More
Select for export If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpain.2022.05.003 PubMed 35643270 Copy citation Copy BibTeX The journal of pain 2022-09-30 Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S PubMed Published psilocybin Chronic PainHeadache / MigraineMechanism of Action Clinical Trial More
Select for export New investigational agents for the treatment of major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/13543784.2022.2113376 PubMed 35975761 Copy citation Copy BibTeX Expert opinion on investigational drugs 2022-09-30 Pochwat B, Krupa AJ, Siwek M, Szewczyk B PubMed Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Review Article More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.